456
Can. J. Chem. Vol. 84, 2006
ArH). 13C NMR (50.4 MHz) δ: 24.3, 27.8, 34.0, 54.7, 123.2,
127.2, 127.6, 129.2, 130.0, 130.8, 131.6, 134.9, 161.8,
172.7. MS m/z: 324.5 (M+).
Acknowledgements
Vipan Kumar is grateful to the Council of Scientific and
Industrial Research (CSIR, New Delhi) for a Junior Re-
search Fellowship under grant No. 01(1590)/99/EMR-II. The
authors also gratefully acknowledge the support of Professor
Takao Saito and Dr. Takashi Otani of the Tokyo University
of Science (Japan) for providing high resolution NMR and
1H–1H correlation spectra.
N-Cyclohexyl-N′-(4-nitro-benzylidene)benzamidine (4c)
1
Melting point: 140 to 141 °C. H NMR (200 MHz) δ:
1.42–1.88 (m, 10H, cyclohexyl), 3.29 (m, 1H, cyclohexyl),
7.16–7.20 (d, 2H, J = 8.2 Hz, ArH), 7.34–7.38 (d, 2H, J =
8.2 Hz, ArH), 7.40–7.46 (m, 3H, ArH), 8.00–8.04 (m, 2H,
ArH). 13C NMR (50.4 MHz) δ: 24.7, 28.0, 33.8, 54.5, 123.7,
126.8, 127.7, 129.4, 130.1, 131.0, 131.5, 135.0, 162.1,
171.9. MS m/z: 335 (M+).
References
1. For recent reviews on azadienes, see: (a) D.L. Boger. Tetrahe-
dron, 39, 2869 (1983); (b) D.L. Boger. Chemtracts: Org.
Chem. 9, 149 (1996); (c) J. Barluenga and M. Tomas. Adv.
Heterocycl. Chem. 57, 1 (1993); (d) M. Behforonz and M.
Ahmadian. Tetrahedron, 56, 5259 (2000); (e) S. Jayakumar,
M.P.S. Ishar, and M.P. Mahajan. Tetrahedron, 58, 379 (2002).
Tetrahedron Report No. 595.
2. P. Molina and M.J. Vilaplana. Synthesis, 1197 (1994).
3. J. Barluenga and F. Palacios. Org. Prep. Proced. Int. 23, 1
(1991).
N-Cyclohexyl-N′-(2-hydroxy-benzylidene)benzamidine
(4d)
1
Product: oily liquid. H NMR (200 MHz) δ: 1.37–1.82
(m, 10H, cyclohexyl), 3.32 (m, 1H, cyclohexyl), 6.89–8.44
(m, 10H, 9H arom + 1H olefinic), 11.1 (s, 1H, -OH ex-
changeable with D2O). 13C NMR (50.4 MHz) δ: 24.57,
30.28, 34.73, 54.53, 127.23, 128.14, 129.20, 130.20, 131.53,
131.86, 133.38, 134.54, 135.0, 137.42, 165.24, 170.83. MS
m/z: 306 (M+).
4. S. Jayakumar, V. Kumar, and M.P. Mahajan. Tetrahedron Lett.
42, 2235 (2001).
5. (a) E. Rossi and R. Stradi. Synthesis, 214 (1989); (b) E. Rossi,
R. Stradi, and P. Visentin. Tetrahedron, 46, 3581 (1990).
6. V. Kumar, A.K. Sharma, and M.P. Mahajan. Synth. Commun.
34, 49 (2004).
2-(4-Methoxy-phenyl)-4,6-diphenyl-[1,3,5]triazine (8a)
Melting point: 198 to 199 °C. H NMR (200 MHz) δ:
1
3.82 (s, 3H, -OCH3), 6.82–6.86 (d, 2H, J = 8.6 Hz, ArH),
7.52–7.58 (m, 6H, ArH), 8.60–8.64 (d, 2H, J = 8.6 Hz,
ArH), 8.70–8.76 (m, 4H, ArH). 13C NMR (50.4 MHz) δ:
55.2 (-OCH3), 111.1, 123.1, 128.1, 128.5, 130.2, 132.0,
136.2, 152.9, 170.8, 171.3. MS m/z: 339 (M+). Anal. calcd.
for C22H17N3O (%): C 77.86, H 5.05, N 12.38; found: C
77.72, H 5.11, N 12.46.
7. V. Kumar, C. Mohan, M. Gupta, and M.P. Mahajan. Tetrahe-
dron. In press.
8. (a) D.H. Hunter and S.K. Sim. Can. J. Chem. 50, 669 (1972);
(b) P. Luthardt, M.H. Moller, U. Rodeweld, and E.-U.
Wurthwein. Chem. Rev. 122, 1705 (1989); (c) A.C. Veronese,
R. Callegari, and C.F. Morelli. Tetrahedron, 51, 12277 (1995).
9. E. Rossi, G. Abbiati, and E. Pini. Tetrahedron, 53, 14107
(1997).
10. (a) S.N. Mazumdar, I. Ibnusaud, and M.P. Mahajan. Tetrahe-
dron Lett. 28, 2641 (1987); (b) S.N. Mazumdar and M.P.
Mahajan. Tetrahedron, 47, 1473 (1991); (c) S.N. Mazumdar, S.
Mukherjee, A.K. Sharma, D. Sengupta, and M.P. Mahajan.
Tetrahedron, 50, 7579 (1994); (d) S. Mukherjee, S.N.
Mazumdar, A.K. Sharma, and M.P. Mahajan. Heterocycles, 47,
933 (1998); (e) P.D. Dey, A.K. Sharma, P.V. Bharatam, and
M.P. Mahajan. Tetrahedron, 53, 13829 (1997); ( f ) A.K.
Sharma, S. Jayakumar, M.S. Hundal, and M.P. Mahajan. J.
Chem. Soc. Perkin. Trans. 1, 774 (2002), and refs. cited
therein.
[4-(4,6-Diphenyl-[1,3,5]triazin-2-yl)phenyl]dimethyl-
amine (8b)
1
Melting point: 211 to 212 °C. H NMR (200 MHz) δ:
3.11 (s, 6H, -N(CH3)2), 6.87–6.91 (d, 2H, J = 8.8 Hz, ArH),
7.54–7.60 (m, 6H, ArH), 8.62–8.66 (d, 2H, J = 8.8 Hz,
ArH), 8.74–8.79 (m, 4H, ArH). 13C NMR (50.4 MHz) δ:
40.2 (-N(CH3)2), 111.3, 123.6, 128.4, 128.9, 130.7, 132.0,
136.9, 153.4, 171.0, 171.5. MS m/z: 352 (M+). Anal. calcd.
for C23H20N4 (%): C 78.38, H 5.72, N 15.90; found: C
78.23, H 5.74, N 16.03.
11. R.S. Verma, É. Rimán, and T. Patonay. ARKIVOC, Part (vii),
183 (2004).
Conclusion
12. (a) H. Bader. J. Org. Chem. 30, 707 (1965); (b) C. Chen, R.
Dagnino, and J.R. McCarthy. J. Org. Chem. 60, 8428 (1995);
(c) Y. Peng and G. Song. Tetrahedron Lett. 45, 5313 (2004);
(d) L.D.S. Yadav and R. Kapoor. Tetrahedron Lett. 44, 8951
(2003).
13. M. Ono, N. Kawahara, D. Goto, Y. Wakahayashi, S. Ushiro, S.
Yoshida, H. Izumi, M. Kuwano, and Y. Sato. Cancer Res. 56,
1512 (1996).
The simple and convenient method presented for the syn-
thesis of 1,3,5-triazines (12) is of significance because of the
limited methods available and the broad range of their bio-
logical activities, including antiangiogenesis (13), herbicidal
effects (14), antimetastatic effects (15), Erm methylenetrans-
ferase inhibition (16), and anti-microbial effects (17). The
strategy is of further significance because of the lack of suit-
able methods for the synthesis of acyclic 1,3-diazabuta-1,3-
dienes with aryl substituents at the C-4 position. Such acy-
clic dienes can prove to be useful substrates for studying the
stereochemical aspects of their cycloaddition reactions.
14. W. Draber, K. Tietjen, J.F. Kluth, and A. Trebst. Angew.
Chem. Int. Ed. Engl. 30, 1621 (1991).
15. M. Maeda, M. Iogo, H. Tsuda, H. Fujita, Y. Yonemura, K.
Nagakawa, Y. Endo, and T. Sasaki. Anti-Cancer Drug Des. 15,
217 (2000).
© 2006 NRC Canada